| Literature DB >> 25231826 |
Krzysztof Góralczyk1, Justyna Szymańska, Małgorzata Łukowicz, Ewelina Drela, Roman Kotzbach, Mariusz Dubiel, Małgorzata Michalska, Barbara Góralczyk, Andrzej Zając, Danuta Rość.
Abstract
Growth factors as vascular endothelial growth factor (VEGF), produced by the endothelial cells, take an essential part in pathological and physiological angiogenesis. The possibility of angiogenesis modulation by application of laser radiation may contribute to the improvement of its use in this process. Thus, the aim of the study was to investigate the influence of low-level laser therapy (LLLT) on the proliferation of endothelial cells, secretion of VEGF-A and presence of soluble VEGF receptors (sVEGFR-1 and sVEGFR-2) in the medium after in vitro culture. Isolated human umbilical vein endothelial cells (HUVECs) were irradiated using a diode laser at a wavelength of 635 nm and power density of 1,875 mW/cm(2). Depending on radiation energy density, the experiment was conducted in four groups: I 0 J/cm(2) (control group), II 2 J/cm(2), III 4 J/cm(2), and IV 8 J/cm(2). The use of laser radiation wavelength of 635 nm, was associated with a statistically significant increase in proliferation of endothelial cells (p = 0.0041). Moreover, at 635-nm wavelength, all doses of radiation significantly reduced the concentration of sVEGFR-1 (p = 0.0197).Entities:
Mesh:
Substances:
Year: 2014 PMID: 25231826 PMCID: PMC4289014 DOI: 10.1007/s10103-014-1650-0
Source DB: PubMed Journal: Lasers Med Sci ISSN: 0268-8921 Impact factor: 3.161
Fig. 1Number of HUVECs, depending on LLLT dose with the wavelength of 635 nm. Values are expressed as the mean ± SEM. Asterisk above bars indicate significant differences vs. control group (*p < 0.01)
Fig. 2Concentration of VEGF-A in the supernatant, depending on LLLT dose with the wavelength of 635 nm (p = 0.08). Values are expressed as the mean ± SEM
Fig. 3Concentration of sVEGFR-1 in the supernatant, depending on LLLT dose with the wavelength of 635 nm. Values are expressed as the mean ± SEM. Asterisk above bars indicate significant differences vs. control group (*p < 0.01)
Fig. 4Concentration of sVEGFR-2 in the supernatant, depending on LLLT dose with the wavelength of 635 nm (p = 0.23). Values are expressed as the mean ± SEM
Fig. 5The hypothesis of the action of VEGF-A and soluble receptors sVEGFR-1 and sVEGFR-2 in the supernatant. a The connection of VEGF-A with VEGFR-2 receptor located on the cell membrane contributes to endothelial cell proliferation. b Competitive VEGF-A binding with soluble forms of receptors sVEGFR-1 and sVEGFR-2 present in the supernatant leads to reducing endothelial proliferation